K M Cummings
Overview
Explore the profile of K M Cummings including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
174
Citations
4913
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wadsworth E, McNeill A, Li L, Hammond D, Thrasher J, Yong H, et al.
Prev Med
. 2018 Apr;
112:130-137.
PMID: 29678615
Electronic cigarette (e-cigarette) advertising regulations differ across countries. This study examines how differences in e-cigarette advertising regulations influence exposure to e-cigarette advertising, and perceptions about what participants had seen and...
2.
Cummings K, Kelly J, Sciandra R, Deloughry T, Francois F
Am J Health Promot
. 2011 Dec;
4(6):429-34.
PMID: 22204621
Abstract This paper presents the results of a follow-up evaluation conducted to assess the impact of a community-wide stop smoking contest conducted in Buffalo, New York in January 1988. The...
3.
Emont S, Cummings K
Am J Health Promot
. 2011 Dec;
5(2):107-14.
PMID: 22188192
Abstract The effects of organizational factors on participation rates in a smoking cessation clinic and on one-year quit rates were examined among 68 private sector businesses. Free smoking cessation programs...
4.
Fix B, OConnor R, Fong G, Borland R, Cummings K, Hyland A
BMC Public Health
. 2011 Dec;
11:941.
PMID: 22177316
Background: On June 22, 2009, the US FDA was granted the authority to regulate tobacco products through the Family Smoking Prevention and Tobacco Control Act (FSPTCA). The intent is to...
5.
Hawk Jr L, Ashare R, Lohnes S, Schlienz N, Rhodes J, Tiffany S, et al.
Clin Pharmacol Ther
. 2011 Dec;
91(2):172-80.
PMID: 22130118
Preclinical research and learning theory suggest that a longer duration of varenicline treatment prior to the target quit date (TQD) would reduce smoking rates before cessation and improve abstinence outcomes....
6.
OConnor R, Wilkins K, Caruso R, Cummings K, Kozlowski L
Public Health
. 2010 Oct;
124(12):667-74.
PMID: 21030055
Objectives: The public health burden of tobacco use is shifting to the developing world, and the tobacco industry may apply some of its successful marketing tactics, such as allaying health...
7.
Elton-Marshall T, Fong G, Zanna M, Jiang Y, Hammond D, OConnor R, et al.
Tob Control
. 2010 Oct;
19 Suppl 2:i54-62.
PMID: 20935197
Background: Many smokers in Western countries perceive "light" or "low tar" cigarettes as less harmful and less addictive than "regular" or "full flavoured" cigarettes. However, there is little research on...
8.
Cummings K, Coogan K
Int Q Community Health Educ
. 2010 Sep;
13(1):77-86.
PMID: 20841232
In New York State, it is illegal to sell tobacco products to persons under the age of eighteen. A 1989 survey of 120 retail stores in Erie County, New York,...
9.
Mattson M, Cummings K, Lynn W, Giffen C, Corle D, Pechacek T
Int Q Community Health Educ
. 2010 Sep;
11(3):271-90.
PMID: 20840953
The National Cancer Institute is sponsoring the Community Intervention Trial for Smoking Cessation (COMMIT), a multi-center research project designed to test the value of a community-based effort to promote smoking...
10.
Rotstein C, Cummings K, Nicolaou A, Lucey J, Fitzpatrick J
Infect Control Hosp Epidemiol
. 2009 Sep;
9(1):13-9.
PMID: 19722932
Nosocomial infection rates were computed for 5,031 patients at an oncology center during a 20-month period. Twelve percent of the patients developed nosocomial infections, accounting for a total of 802...